Matej H, Olearczyk J, Partyka T, Kotlarek-Haus S, Stawarz M, Dzierzkowa-Borodej W
Arch Immunol Ther Exp (Warsz). 1975;23(2):181-7.
A panel of 150 Rh+ and Rh-- donors was tested by the NIH-microcytotoxicity test against 90 antisera determing 21 HL-A antigens. For platelet and leukocyte transfusions, donors compatible in ABO and Rh groups as well as in HL-A antigens, were used. In some cases the donor and recipient were compatible in three HL-A antigens, in other cases the degree of compatibility was less satisfactory. Platelet and leukocyte concentrates were prepared by double thrombo- and leukocyte-pheresis. Before transfusions the cross cytotoxicity test with donor's lymphocytes was performed. No transfusion accidents occurred; in some patients a beneficial effect was noticed.
采用美国国立卫生研究院微量细胞毒性试验，对150名Rh阳性和Rh阴性供血者进行检测，以对抗90种能确定21种人类白细胞抗原（HL-A抗原）的抗血清。对于血小板和白细胞输血，使用ABO血型、Rh血型以及HL-A抗原均相匹配的供血者。在某些情况下，供血者与受血者在三种HL-A抗原上相匹配，而在其他情况下，匹配程度则不太理想。血小板浓缩液和白细胞浓缩液通过双重血栓和白细胞单采术制备。输血前，对供血者淋巴细胞进行交叉细胞毒性试验。未发生输血事故；在一些患者中观察到了有益效果。
